MedPath

海南美好西林生物制药有限公司

Ownership
-
Established
2007-12-24
Employees
-
Market Cap
-
Website
www.merocilline.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

57

NMPA:57

Drug Approvals

Mezlocillin sodium and Sulbactam sodium for Injection

Product Name
注射用美洛西林钠舒巴坦钠
Approval Number
国药准字H20193213
Approval Date
Jul 2, 2024
NMPA

Mezlocillin sodium and Sulbactam sodium for Injection

Product Name
注射用美洛西林钠舒巴坦钠
Approval Number
国药准字H20193212
Approval Date
Jul 2, 2024
NMPA

Cefoperazone Sodium and Tazobactam Sodium for Injection(Ⅰ)

Product Name
注射用头孢哌酮钠他唑巴坦钠(Ⅰ)
Approval Number
国药准字H20183492
Approval Date
Dec 6, 2023
NMPA

Cefodizime Sodium for Injection

Product Name
注射用头孢地嗪钠
Approval Number
国药准字H20183484
Approval Date
Dec 5, 2023
NMPA

Cefoperazone Sodium and Tazobactam Sodium for Injection(Ⅰ)

Product Name
注射用头孢哌酮钠他唑巴坦钠(Ⅰ)
Approval Number
国药准字H20183493
Approval Date
Dec 5, 2023
NMPA

Cefodizime Sodium for Injection

Product Name
注射用头孢地嗪钠
Approval Number
国药准字H20183485
Approval Date
Dec 5, 2023
NMPA

Flucloxacillin Sodium for Injection

Product Name
注射用氟氯西林钠
Approval Number
国药准字H20183393
Approval Date
Aug 4, 2023
NMPA

Cefodizime Sodium for Injection

Product Name
注射用头孢地嗪钠
Approval Number
国药准字H20183486
Approval Date
Jun 28, 2023
NMPA

Ampicillin Sodium and Sulbactam Sodium for Injection

Product Name
注射用氨苄西林钠舒巴坦钠
Approval Number
国药准字H20084209
Approval Date
May 4, 2023
NMPA

Amoxicillin Sodium and Clavulanate Potassium for Injection

Product Name
注射用阿莫西林钠克拉维酸钾
Approval Number
国药准字H20084112
Approval Date
May 4, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.